Changes in Penile Firmness With Low-Intensity Shockwave Therapy (LiST)

Sponsor
Northwell Health (Other)
Overall Status
Recruiting
CT.gov ID
NCT05756803
Collaborator
(none)
20
2
1
23.4
10
0.4

Study Details

Study Description

Brief Summary

Patients presenting with erectile dysfunction are often found to have increased corporal firmness on elastography. We hypothesize that this corporal firmness reflects reversable changes that can be altered by Low-Intensity Shockwave Therapy (LiST). In this pilot study patients found to have increased corporal firmness will be treated with LiST.

Condition or Disease Intervention/Treatment Phase
  • Device: Low-intensity acoustic shockwave therapy
N/A

Detailed Description

This study will enroll men between the ages of 18 and 65 with corporal cavernosal firmness on elastography. The participants study duration is 3 months long and includes eight visits at the study center. Study visits consist of physical exam, vital signs, questionnaires, blood draws, and administration of low-intensity shockware therapy (LiST).

Low intensity extracorporeal (i.e., outside the body) shockwave therapy (LiST) is a treatment that has been in use since 2010 and has become commonly used Internationally and in the United States since 2015. The device applies a low-intensity shockwave to the surface of the penis using an ultrasound gel as the coupling agent.

The study will evaluate changes in corporal cavernosal firmness and changes in penile vascular blood flow.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Changes in Penile Firmness With Low-Intensity Shockwave Therapy (LiST)
Anticipated Study Start Date :
Mar 5, 2023
Anticipated Primary Completion Date :
Feb 15, 2025
Anticipated Study Completion Date :
Feb 15, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low Intensity Acoustic Shockwave Therapy

The device applies a low-intensity shockwave to the surface of the penis using an ultrasound gel as the coupling agent. The low-intensity shockwave therapy device will be used with the purpose of improving penile blood flow and restoring sexual function in men with impaired erectile function.

Device: Low-intensity acoustic shockwave therapy
The study is being done to find out if low-intensity shockwave therapy can improve penile blood flow and restore sexual function in men with impaired erectile function.

Outcome Measures

Primary Outcome Measures

  1. Evaluate changes in corporal cavernosal firmness with Low-Intensity Acoustic Shockwave Therapy (LiST) [12 Weeks]

    Change in corporal firmness (KPa) with Low-Intensity Acoustic Shockwave Therapy (LiST)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Provision of signed and dated informed consent form

  2. Stated willingness to comply with all study procedures and availability for the duration of the study

  3. Men aged 18-64

  4. Sexually active men and evidence of increased firmness on elastography during their standard evaluation for erectile dysfunction.

Exclusion Criteria:
  1. Within two weeks of Visit 1 using erectogenic medications including PDE5 inhibitors and/or penile injection therapy

  2. Presence of a penile implant.

  3. Presence of cardiac pacemaker or defibrillator

  4. Patients who are using devices which are sensitive to electromagnetic radiation.

  5. Screening ultrasound positive for testicular cancer

  6. Presence of untreated prostate cancer

  7. Patients with severe coagulation disorders

  8. Patient that in the opinion of the Principal Investigator would be non-compliant with the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dr. Gilbert's Office Great Neck New York United States 11021
2 The Smith Institute for Urology Lake Success New York United States 11042

Sponsors and Collaborators

  • Northwell Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bruce Gilbert, Vice Chairperson, Northwell Health
ClinicalTrials.gov Identifier:
NCT05756803
Other Study ID Numbers:
  • LiST-001
First Posted:
Mar 6, 2023
Last Update Posted:
Mar 6, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2023